NDC product
Promethazine Hydrochloride and Dextromethorphan Hydrobromide
NDC 27808-057 · Cranbury Pharmaceuticals, LLC
Key facts
| Product NDC | 27808-057 |
|---|---|
| Proprietary name | Promethazine Hydrochloride and Dextromethorphan Hydrobromide |
| Nonproprietary name | Promethazine Hydrochloride and Dextromethorphan Hydrobromide |
| Substances | PROMETHAZINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Cranbury Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA091687 |
| Pharmacologic classes | Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| Marketing start | Jan 31, 2014 |
| Marketing end | Apr 1, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory